Drawing for MYOBENONE

USPTO serial 78320752

MYOBENONE

Reviewed by CopyMark Law Group

Reg. 3078478Status 710
Filing date
Status date
Registration date
Apr 11, 2006
Examiner
GARDNER, DAWNA BERYL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MYOBENONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

S. Peter Ludwig, Amy J. Benjamin and Karin Segall

S PETER LUDWIG ET AL DARBY & DARBY PCPO BOX 5257NEW YORK, NY 10150-5257UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and scienceSECTION 8 - CANCELLED—
005Pharmaceutical, veterinary and sanitary preparations, namely, chemical products for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory lossSECTION 8 - CANCELLED—
042Computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific research for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases; scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory lossSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 16, 2012C8..CANCELLED SEC. 8 (6-YR)—
Apr 11, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 17, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 28, 2005NPUBNOTICE OF PUBLICATION—
Dec 5, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 5, 2005ALIEASSIGNED TO LIE—
Sep 1, 2005ALIEASSIGNED TO LIE—
Aug 23, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 4, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 20, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 28, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2005GNSIINQUIRY TO SUSPENSION E-MAILED—
Jun 3, 2005CNSISUSPENSION INQUIRY WRITTEN—
May 16, 2005RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 1, 2004GNSLLETTER OF SUSPENSION E-MAILED—
Nov 1, 2004CNSLSUSPENSION LETTER WRITTEN—
Sep 29, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 17, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2004MAILPAPER RECEIVED—
Mar 20, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2004DOCKASSIGNED TO EXAMINER—
Nov 21, 2003NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance